Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDTreace Medical Concepts Inc Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 1 | -$0.32 | -$0.30 | -$0.31 |
| Q2 2026 | 1 | -$0.29 | -$0.28 | -$0.28 |
| Q3 2026 | 1 | -$0.25 | -$0.24 | -$0.25 |
| Q4 2026 | 1 | -$0.07 | -$0.06 | -$0.06 |
| Q1 2027 | 1 | -$0.27 | -$0.26 | -$0.26 |
| Q2 2027 | 1 | -$0.27 | -$0.26 | -$0.26 |
| Q3 2027 | 1 | -$0.22 | -$0.21 | -$0.22 |
| Q4 2027 | 1 | $0.00 | $0.01 | $0.01 |
| Q1 2028 | 1 | -$0.21 | -$0.20 | -$0.20 |
| Q2 2028 | 1 | -$0.22 | -$0.21 | -$0.21 |
| Q3 2028 | 1 | -$0.17 | -$0.16 | -$0.16 |
| Q4 2028 | 1 | $0.09 | $0.09 | $0.09 |
Treace Medical Concepts Inc Earnings Date And Information
Treace Medical Concepts Inc last posted its earnings results on Friday, February 27th, 2026. The company reported $-0.12 earnings per share for the quarter, topping analysts' consensus estimates of $-0.1519 by $0.0319. The company had revenue of 62.52 M for the quarter and had revenue of 212.69 M for the year. Treace Medical Concepts Inc has generated $-1 earnings per share over the last year ($-0.93 diluted earnings per share) and currently has a price-to-earnings ratio of -2.08. Treace Medical Concepts Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Treace Medical Concepts Inc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 02/27/2026 | Q4 2025 | -$0.15 | -$0.15 | 0 | $61.85 M | $62.52 M |
| 11/06/2025 | Q3 2025 | -$0.28 | -$0.26 | 0.02 | $49.83 M | $50.21 M |
| 08/07/2025 | Q2 2025 | -$0.29 | -$0.28 | 0.01 | $47.05 M | $47.39 M |
| 05/08/2025 | Q1 2025 | -$0.31 | -$0.25 | 0.06 | $52.06 M | $52.57 M |
| 02/27/2025 | Q4 2024 | -$0.04 | -$0.01 | 0.03 | $67.25 M | $68.71 M |
| 11/05/2024 | Q3 2024 | -$0.27 | -$0.25 | 0.02 | $43.48 M | $45.09 M |
| 08/06/2024 | Q2 2024 | -$0.29 | -$0.34 | -0.05 | $43.00 M | $44.46 M |
| 05/07/2024 | Q1 2024 | -$0.30 | -$0.30 | 0 | $49.07 M | $51.11 M |
| 02/27/2024 | Q4 2023 | -$0.09 | -$0.10 | -0.01 | N/A | $62.21 M |
| 11/09/2023 | Q3 2023 | -$0.26 | -$0.28 | -0.02 | N/A | $40.76 M |
| 08/09/2023 | Q2 2023 | N/A | -$0.20 | N/A | N/A | $41.95 M |
| 05/09/2023 | Q1 2023 | N/A | -$0.22 | N/A | N/A | $42.20 M |
| 03/08/2023 | Q4 2022 | N/A | -$0.06 | N/A | N/A | $49.77 M |
| 11/09/2022 | Q3 2022 | N/A | -$0.23 | N/A | N/A | $33.06 M |
| 08/10/2022 | Q2 2022 | N/A | -$0.31 | N/A | N/A | $29.97 M |
| 05/06/2022 | Q1 2022 | N/A | -$0.18 | N/A | N/A | $29.05 M |
| 03/04/2022 | Q4 2021 | N/A | -$0.12 | N/A | N/A | $33.44 M |
| 11/04/2021 | Q3 2021 | -$0.12 | -$0.12 | 0 | N/A | $21.62 M |
| 08/05/2021 | Q2 2021 | -$0.12 | -$0.10 | 0.02 | N/A | $20.65 M |
| 05/25/2021 | Q1 2021 | -$0.08 | -$0.05 | 0.03 | N/A | $18.71 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Treace Medical Concepts Inc Earnings: FAQ's
In the previous quarter, Treace Medical Concepts Inc (:TMCI) reported $-0.12 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.1519 by $0.0319.
The conference call for Treace Medical Concepts Inc's latest earnings report can be listened to online.
The conference call transcript for Treace Medical Concepts Inc's latest earnings report can be read online.
Treace Medical Concepts Inc (:TMCI) has a recorded annual revenue of $212.69 M.
Treace Medical Concepts Inc (:TMCI) has a recorded net income of $-59,002,000.Treace Medical Concepts Inc has generated $-0.93 earnings per share over the last four quarters.
Treace Medical Concepts Inc (:TMCI) has a price-to-earnings ratio of -2.08 and price/earnings-to-growth ratio is 0.26.